This Medtech Company Is Bringing "Precision" Medicine To Cardiovascular Diagnostics

  • 15 days ago
Meesha Dogan, PhD, CEO, Co-Founder and Director of Cardio Diagnostics, was recently a guest on Benzinga's All-Access.

Cardio Diagnostics makes cardiovascular disease prevention and early detection more accessible, personalized and precise. Its proprietary AI platform called Genetic-Epigenetic Engine is designed to help healthcare professionals better detect and diagnose coronary heart disease and tailor treatment "precisely" to each patient.

Ms. Dogan spoke about the innovative approach and how her company is the only one doing it in the cardiovascular space.

Recommended